Analyst Activity – HC Wainwright Reiterates Buy on CymaBay Therapeutics (NASDAQ:CBAY)

ME Staff
-
0

Analyst Ratings For CymaBay Therapeutics (NASDAQ:CBAY)

Today, HC Wainwright reiterated its Buy rating on CymaBay Therapeutics (NASDAQ:CBAY) with a price target of $18.00.

Some recent analyst ratings include

  • 1/24/2018-HC Wainwright Reiterated Rating of Buy .
  • 11/28/2017-Leerink Swann Reiterated Rating of Buy.
  • 11/8/2017-Cantor Fitzgerald Reiterated Rating of Buy.
  • 10/27/2017-Piper Jaffray Companies Reiterated Rating of Buy.
  • 8/18/2017-SunTrust Banks initiated coverage with a Buy rating.
  • 8/11/2017-Ifs Securities was Downgraded by analysts at Ifs Securities from a “Strong-Buy ” rating to a ” Outperform” rating.

Recent Insider Trading Activity For CymaBay Therapeutics (NASDAQ:CBAY)
CymaBay Therapeutics (NASDAQ:CBAY) has insider ownership of 15.10% and institutional ownership of 69.12%.

  • On 1/19/2018 Kurt Von Emster, Director, sold 144,216 with an average share price of $10.25 per share and the total transaction amounting to $1,478,214.00.
  • On 1/5/2018 Kurt Von Emster, Director, sold 4,300 with an average share price of $10.21 per share and the total transaction amounting to $43,903.00.
  • On 12/22/2017 Kurt Von Emster, Director, sold 173,192 with an average share price of $9.41 per share and the total transaction amounting to $1,629,736.72.
  • On 11/10/2017 Kurt Von Emster, Director, sold 50,048 with an average share price of $9.26 per share and the total transaction amounting to $463,444.48.
  • On 11/2/2017 Carl Goldfischer, Director, sold 18,000 with an average share price of $8.66 per share and the total transaction amounting to $155,880.00.
  • On 11/2/2017 Charles Mcwherter, SVP, bought 5,000 with an average share price of $8.67 per share and the total transaction amounting to $43,350.00.
  • On 10/31/2017 Kurt Von Emster, Director, sold 59,209 with an average share price of $9.27 per share and the total transaction amounting to $548,867.43.

Recent Trading Activity for CymaBay Therapeutics (NASDAQ:CBAY)
Shares of CymaBay Therapeutics closed the previous trading session at 11.24 up +0.52 4.80% with 10.859999656677246 shares trading hands.